DATE: April 23, 2019
TIME: 11:00am PDT, 2:00pm EDT
Cataract, a clouding of the ocular lens, is the leading cause of blindness worldwide. Currently the only means of treatment is through surgical intervention. Given the sheer prevalence of cataract worldwide, surgical intervention places a significant financial burden on the health-care system. Hence, there is a need to develop pharmacological treatments to maintain the transparency of the lens. This webinar will explore the molecular and cellular basis of how cataract forms with a particular focus on the role of transforming growth factor-beta (TGFβ) and its downstream signaling pathways. The Lens Research Laboratory at the University of Sydney led by Professor Frank Lovicu seeks to unravel the complex interplay of growth factor signaling pathways involved in the formation of cataract and in doing so, find novel drug targets to combat cataract. The lens epithelial explant culture system was developed in the Lens Research Laboratory in the 1980s and has enabled the discovery of many now well-accepted phenomena about lens epithelial cell behavior. Using this model, observations can be made while primary lens epithelial cells are adherent to their native basement membrane, known as the lens capsule, thus enabling a closer representation of the in vivo situation compared to This webinar will explain how lens epithelial explants are generated and utilized for experiments.
- Understand basic ocular lens anatomy and how disruption of this anatomy can result in lens pathology known
- Understand how lens epithelial explants are generated and how they can be applied to explore lens epithelial
cell behavior and how cataract forms
- Understand the role of transforming growth factor-beta (TGFβ) and its downstream signaling pathways in cataract formation
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.